URETHRAL NEOPLASMS

Clinical trials for URETHRAL NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new URETHRAL NEOPLASMS trials appear

Sign up with your email to follow new studies for URETHRAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1 Terminated 1

New hope for rare cancers: immunotherapy trial targets tumors regardless of origin

Disease control Recruiting now

This study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.

Matched conditions: URETHRAL NEOPLASMS

Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control

Last updated May 17, 2026 05:34 UTC

URETHRAL NEOPLASMS

Get alerted when new URETHRAL NEOPLASMS trials appear

New hope for rare cancers: immunotherapy trial targets tumors regardless of origin